Immunic Therapeutics, is a clinical-stage biopharmaceutical company specialising in immunological therapies focused on treating chronic inflammatory and autoimmune diseases. They are currently researching the safety and tolerability of an oral therapy IMU-856, at four clinical research sites in New Zealand, based in Auckland, Hawke's Bay, Palmerston North, and Wellington. IMU-856 is proposed to have the […]